We previously showed circulating IFN‐α declines during the first 6 months after RA diagnosis,4 potentially explaining this difference from eRA, although the influence of distinct cellular composition and/or sampling technique cannot be excluded. This evidence concerns the gene IFNA2 and rheumatoid arthritis.